GlaxoSmithKline Pharmaceuticals informs about disclosure

26 Aug 2024 Evaluate
GlaxoSmithKline Pharmaceuticals has informed that the Company has received an Order dated 24th August 2024 from Punjab State GST authorities, dropping proceedings with respect to Show Cause Notice issued alleging non-payment of Cess amount disclosed in E-way bill.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2380.90 3.25 (0.14%)
20-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1777.45
Dr. Reddys Lab 1298.95
Cipla 1255.85
Zydus Lifesciences 890.60
Lupin 2322.45
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×